Clinical trial
Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who…
NCT00427713 · Cancer Research UK, Other · Completed
Key facts
| NCT number | NCT00427713 |
|---|---|
| Title | Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer |
| Official title | Chemotherapy or No Chemotherapy in Clear Margins After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. A Randomised Phase III Trial of Control Vs Capecitabine Plus Oxaliplatin [CHRONICLE] |
| Lead sponsor | Cancer Research UK, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | capecitabine, oxaliplatin, adjuvant therapy, standard follow-up care |
| Enrollment | 800 |
| Start date | Nov 1, 2004 |
| Primary completion | Mar 1, 2008 |
| First posted | Jan 29, 2007 |
| Last update posted | Aug 26, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: